Retrieve Medical Holdings, Inc. (RMHI) Cash & Equivalents (2010 - 2022)

Retrieve Medical Holdings (RMHI) has 13 years of Cash & Equivalents data on file, last reported at $96720.0 in Q4 2022.

• Cash & Equivalents for Q4 2022 came in at $96720.0, down 48.43% year-over-year; the trailing twelve-month figure through Dec 2022 was $96720.0 (down 48.43% YoY), and the FY2022 annual result was $127599.0, down 51.14% from the prior year.
• Cash & Equivalents slipped to $96720.0 in Q4 2022 per RMHI's latest filing, from $127599.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $261152.0 in Q3 2021 and troughed at $348.0 in Q1 2021.
• A 5-year average of $55360.1 and a median of $2270.0 in 2018 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2019 and 2021: Cash & Equivalents slumped 96.79% in 2019, then surged 63907.84% in 2021.
• A 5-year view of Cash & Equivalents shows it stood at $764.0 in 2018, then tumbled by 34.82% to $498.0 in 2019, then fell by 24.1% to $378.0 in 2020, then soared by 49517.46% to $187554.0 in 2021, then plunged by 48.43% to $96720.0 in 2022.
• Business Quant data shows RMHI's Cash & Equivalents at $96720.0 in Q4 2022, $127599.0 in Q3 2022, and $131340.0 in Q2 2022.